Top Markets
#1 Siren Siren +36.59%
#2 Wiki Cat Wiki Cat +33.93%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.19%
#4 Velvet Velvet +17.35%
#5 PulseChain PulseChain +16.72%
#6 The Grays Currency The Grays Currency +16.57%
#7 Ribbita by Virtuals Ribbita by Virtuals +16.22%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +16.20%
#9 Janction Janction +15.94%
#10 aPriori aPriori +15.59%
Coin of the day
Siren Siren
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Diffusion Pharmaceuticals Inc. Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Inc.

DFFN
Rangering i aksjer #31361
As a biopharmaceutical enterprise, Diffusion Pharmaceuticals Inc. concentrates... As a biopharmaceutical enterprise, Diffusion Pharmaceuticals Inc. concentrates on pioneering new treatments that bolster the body's efficiency in oxygen distribution. The company's flagship investigational therapy is Trans Sodium Crocetinate, which is formulated to facilitate the spread of oxygen into tissues. This compound is additionally under development for its application in addressing COVID-19. Headquartered in Charlottesville, Virginia, Diffusion Pharmaceuticals Inc. was established in 2001.
Aksjekurs
$6.60
Sist synkronisert: 2023-08-16
Markedsverdi
$13.46M
Endring (1 dag)
11.68%
Endring (1 år)
0.00%
Land
US
Handel Diffusion Pharmaceuticals Inc. (DFFN)

Kategori

Healthcare
Inntekter for Diffusion Pharmaceuticals Inc. (DFFN)
Inntekter i 2026 TTM: 0
Ifølge Diffusion Pharmaceuticals Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Diffusion Pharmaceuticals Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR